Veralox Therapeutics

VERALOX Therapeutics is a biotechnology company developing first-in-class small molecule therapeutics that target the 12-lipoxygenase (12-LOX) pathway for the treatment of immuno-inflammatory diseases

Biotech & Life Sciences

Sector

Seed

Stage

B2B

Model

01Company Overview

VERALOX Therapeutics is a biotechnology company developing first-in-class small molecule therapeutics that target the 12-lipoxygenase (12-LOX) pathway for the treatment of immuno-inflammatory diseases.

02Backed By1 investor

GCGenesys Capital→

03Similar Companies